Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study

OBJECTIVE: Cariprazine is a dopamine D(3)-preferring D(3)/D(2) and serotonin 5-HT(1A) receptor partial agonist approved to treat adults with schizophrenia and manic/mixed or depressive episodes associated with bipolar I disorder. This study, which is the first to evaluate cariprazine in pediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Paul P., Johnson, Kimball A., Riesenberg, Robert, Orejudos, Amelia, Riccobene, Todd, Kalluri, Hari V., Malik, Paul R., Varughese, Shane, Findling, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458368/
https://www.ncbi.nlm.nih.gov/pubmed/37437109
http://dx.doi.org/10.1089/cap.2022.0097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458368/
https://www.ncbi.nlm.nih.gov/pubmed/37437109
http://dx.doi.org/10.1089/cap.2022.0097

Ejemplares similares